Leonard L. Mazur - Oct 4, 2022 Form 4/A - Amendment Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Executive Chairman, Director, 10%+ Owner
Signature
/s/ Alexander M. Donaldson, by power of attorney
Stock symbol
CTXR
Transactions as of
Oct 4, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/15/2022, 03:05 PM
Date Of Original Report
Oct 6, 2022
Previous filing
Mar 23, 2022
Next filing
Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CTXR Warrant to Purchase Common Stock 1.17M Oct 4, 2022 Common Stock 1.17M $1.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The warrant is fully vested and exercisable immediately.

Remarks:

This amendment is filed to correct an inverted share amount from 1,615,048 to 1,165,048 shares for the warrant expiring on April 5, 2024.